Estrogen And Alzheimers

Estrogen, a hormone primarily involved in female reproductive health, has been linked to Alzheimer's disease (AD) and dementia. Research suggests that estrogen has neuroprotective properties, potentially reducing the risk of AD. It influences brain function by promoting synaptic plasticity, enhancing cerebral blood flow, and reducing inflammation. Postmenopausal women, who experience a significant drop in estrogen levels, show a higher incidence of AD, implying a connection between estrogen deficiency and cognitive decline. Hormone replacement therapy (HRT) has been explored as a preventive measure; however, its efficacy and safety remain controversial, with studies showing mixed results. Understanding estrogen's role in neuroprotection could lead to new therapeutic strategies for combating Alzheimer's and other dementias.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Tags
Facebook
Watsapp